NYSE · NATL
NCR Atleos Corporation
$45.71+$0.42 (+0.93%)
NCR Atleos Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.75% below the high.
Loading market information…
NYSE · GLOB · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Globant S.A.’s quoted price sits in the lower half of its reported 52-week range, 39.42% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Globant S.A.’s next earnings report is currently expected on Nov 12, 2026, with estimated earnings per share of $1.48. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Globant S.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Globant S.A., together with its subsidiaries, provides technology services in the United States, rest of North America, Latin America, Europe, and internationally. The company offers Digital Studio, which integrates artificial intelligence into the software development lifecycle; GUT Studio, which allows clients to better connect brands to end-consumers through experiential marketing; and Enterprise Studio, which leverages tailored technology for streamlined operations and productivity. It also provides AI Industry Studios for the financial services; media, entertainment, sports, and leisure; healthcare and life sciences; CPG, retail, and automotive; gaming and EdTech; airlines; energy, oil, and gas; and high tech and professional services sectors. In addition, the company offers AI Pods, a subscription-based delivery model for AI-powered services; Globant Enterprise AI, an agentic innovation platform; Corporate Hub, which grounds intelligence in how the organization operates; AI Hub, which connects and governs foundation and custom models, enabling industry-specific fine-tuning, continuous evaluation, and optimization; and Agents Hub, which enables autonomous action through the creation and coordination of agents and agentic workflows that operate across systems, teams, and physical environments. Further, it provides various agentic suites, including GeneXus for enterprise systems evolution; Globant CODA for software development; Navigate Digital Twin for process optimization; Navigate Service Assist for support; and Fusion, which enhances marketing, communications, and advertising with AI at the core, as well as StarMeUp, an employee engagement and talent experience platform; and DaXia, an embedded finance accelerator platform. The company has a collaboration with Pharma Mar, S.A. for cancer drug discovery through artificial intelligence. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:23 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 |
|---|
| May 15, 2025 |
| $1.50-5.06% vs estimate |
| $611.09M-1.63% vs estimate |
| Q4 2024 | Feb 20, 2025 | $1.75+0.57% vs estimate | $642.48M-0.3% vs estimate |
|---|
| Q3 2024 | Nov 14, 2024 | $1.63+0.62% vs estimate | $614.67M+0.01% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
29 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 11 contributors · Median target $44.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$45.71+$0.42 (+0.93%)
NCR Atleos Corporation’s quoted price sits in the upper half of its reported 52-week range, 5.75% below the high.
$49.29-$3.73 (-7.04%)
ACM Research, Inc.’s quoted price sits in the lower half of its reported 52-week range, 61.25% below the high.
$15.20-$0.89 (-5.53%)
DXC Technology Company’s quoted price sits in the upper half of its reported 52-week range, 7.2% below the high.
$122.00-$5.99 (-4.68%)
Formula Systems (1985) Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.98% below the high.
$30.34-$0.19 (-0.62%)
Concentrix Corporation’s quoted price sits in the lower half of its reported 52-week range, 32.25% below the high.
$46.17-$1.48 (-3.11%)
Innodata Inc.’s quoted price sits in the lower half of its reported 52-week range, 63.11% below the high.
$2.67+$0.21 (+8.54%)
BigBear.ai Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.57% below the high.
$1.72-$0.04 (-2.27%)
Clarivate Plc’s quoted price sits in the lower half of its reported 52-week range, 55.56% below the high.
